EasyCrossTM Device-Self-centering Catheter

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 12, 2024

Primary Completion Date

July 15, 2024

Study Completion Date

July 15, 2024

Conditions
Transcatheter Aortic Valve Replacement (TAVR)
Interventions
DEVICE

EasyCross™ first-in human

"At T0 the patient will undergo the TAVR procedure including the investigational procedure with the VIVHEART EasyCross™ catheter.~The interventional cardiologist will introduce the VIVHEART EasyCross™ catheter through the femoral artery with a percutaneous access according to the clinical practice through a vascular introducer on an already positioned guidewire. An operator in the procedure room will start a chronometer at this point to measure the investigational device crossing procedure duration.~The VIVHEART EasyCross™ catheter will be progressed into the aorta and up to the aortic valve.~At that time the external part of the VIVHEART EasyCross™ catheter will be opened to allow the self-centering of the catheter on the aortic valve. The guidewire will be introduced and once having crossed the valve the VIVHEART EasyCross™ catheter will be retracted by the physician and removed from the patient's body."

Trial Locations (1)

20132

San Raffaele Scientific Institute, Milan

All Listed Sponsors
lead

Vivheart s.r.l.

INDUSTRY

NCT06412354 - EasyCrossTM Device-Self-centering Catheter | Biotech Hunter | Biotech Hunter